(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione

C19H21BrClN3O4S — CID 31115509

IUPAC(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione
SMILESO=C1[C@H]2CC=CC[C@H]2C(=O)N1CN1CCN(S(=O)(=O)c2ccc(Br)cc2Cl)CC1
InChIInChI=1S/C19H21BrClN3O4S/c20-13-5-6-17(16(21)11-13)29(27,28)23-9-7-22(8-10-23)12-24-18(25)14-3-1-2-4-15(14)19(24)26/h1-2,5-6,11,14-15H,3-4,7-10,12H2/t14-,15+
InChIKeyNRFDFJPCUYREJO-GASCZTMLSA-N
MW502.82 g/mol
LogP2.32
Rot. Bonds4

About (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione

(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione (PubChem CID 31115509) has the molecular formula C19H21BrClN3O4S and a molecular weight of 502.82 g/mol. Its IUPAC name is (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione.

Molecular Properties

Compound Name(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione
PubChem CID31115509
Molecular FormulaC19H21BrClN3O4S
Molecular Weight502.82 g/mol
Exact Mass501.01
IUPAC Name(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione
SMILESO=C1[C@H]2CC=CC[C@H]2C(=O)N1CN1CCN(S(=O)(=O)c2ccc(Br)cc2Cl)CC1
InChIInChI=1S/C19H21BrClN3O4S/c20-13-5-6-17(16(21)11-13)29(27,28)23-9-7-22(8-10-23)12-24-18(25)14-3-1-2-4-15(14)19(24)26/h1-2,5-6,11,14-15H,3-4,7-10,12H2/t14-,15+
InChIKeyNRFDFJPCUYREJO-GASCZTMLSA-N
XLogP2.32
TPSA78.00 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms29
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500502.82
LogP ≤ 52.32
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione?
The IUPAC name of (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione (CID 31115509) is (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione.
What is the SMILES notation for (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione?
The canonical SMILES for (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione is O=C1[C@H]2CC=CC[C@H]2C(=O)N1CN1CCN(S(=O)(=O)c2ccc(Br)cc2Cl)CC1.
What is the InChIKey of (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione?
The InChIKey is NRFDFJPCUYREJO-GASCZTMLSA-N. The full InChI is InChI=1S/C19H21BrClN3O4S/c20-13-5-6-17(16(21)11-13)29(27,28)23-9-7-22(8-10-23)12-24-18(25)14-3-1-2-4-15(14)19(24)26/h1-2,5-6,11,14-15H,3-4,7-10,12H2/t14-,15+.
What are the key properties of (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione?
(3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione has a molecular weight of 502.82 g/mol, XLogP of 2.32, 4 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3aR,7aS)-2-[[4-(4-bromo-2-chlorophenyl)sulfonylpiperazin-1-yl]methyl]-3a,4,7,7a-tetrahydroisoindole-1,3-dione is sourced from PubChem (CID 31115509), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).